Horacio Plotkin
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Horacio Plotkin
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Universidad de Buenos Aires
43
| College/University | Other Consumer Services | 43 |
| Public Company | Pharmaceuticals: Major | 20 | |
| Extinct | Biotechnology | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Horacio Plotkin tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Pontificia Universidad Católica Argentina | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO Director/Board Member | |
| ARCOS DORADOS HOLDINGS INC. | Restaurants | Director/Board Member Director of Finance/CFO Human Resources Officer | |
| San Diego State University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| LOMA NEGRA COMPAÑÍA INDUSTRIAL ARGENTINA SOCIEDAD ANÓNIMA | Construction Materials | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Universidad Torcuato di Tella | College/University | Masters Business Admin Masters Business Admin | |
| Fundacion Loma Negra | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| McDonald's Latin America, LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| Universidad Austral | College/University | Director/Board Member Graduate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| NEUROLOGIX, INC. | Internet Software/Services | Director of Finance/CFO Director/Board Member | |
Empresa Distribuidora de Electricidad de Mendoza Edemsa
 Empresa Distribuidora de Electricidad de Mendoza Edemsa Electric UtilitiesUtilities Empresa Distribuidora de Electricidad de Mendoza EDEMSA engages in the distribution of public electricity within the area. The company was founded in 11 March, 1998 and is headquartered in Mendoza, Argentina. | Electric Utilities | Director/Board Member Director of Finance/CFO | |
| SEER, INC. | Biotechnology | Chief Executive Officer General Counsel | |
| University of California San Diego | College/University | Corporate Officer/Principal Doctorate Degree | |
| TRANSPORTADORA DE GAS DEL SUR S.A. | Gas Distributors | General Counsel General Counsel | |
| Austral Universidad | College/University | Masters Business Admin Masters Business Admin | |
| HUMANIGEN, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| INTEROIL EXPLORATION AND PRODUCTION ASA | Oil & Gas Production | Chairman Director/Board Member | |
| Universidad del CEMA | College/University | Masters Business Admin Masters Business Admin | |
| AMERICAN INTERNATIONAL GROUP, INC. | Multi-Line Insurance | Corporate Officer/Principal Chief Investment Officer | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Chairman | |
| PHARNEXT SCA | Biotechnology | Chief Tech/Sci/R&D Officer | |
| UCB BioSciences, Inc. | Corporate Officer/Principal | ||
| EAGLE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Ironshore Therapeutics, Inc.
 Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chairman | |
| SENSORION | Pharmaceuticals: Major | Chairman | |
| COYA THERAPEUTICS, INC. | Biotechnology | President | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Chairman | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Convergent Therapeutics, Inc.
 Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
| TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 30 |
| Argentina | 10 |
| Canada | 5 |
| Francia | 3 |
| Uruguay | 2 |
Settori
| Health Technology | 22 |
| Consumer Services | 15 |
| Utilities | 4 |
| Commercial Services | 3 |
| Finance | 3 |
Posizioni
| Director/Board Member | 196 |
| Corporate Officer/Principal | 125 |
| Chief Executive Officer | 54 |
| Independent Dir/Board Member | 51 |
| Undergraduate Degree | 50 |
Contatti più connessi
| Insiders | |
|---|---|
| Carrie Cox | 22 |
| Srinivas Rao | 22 |
| John Kozarich | 21 |
| Gary Lyons | 20 |
| Cornelius E. Golding | 18 |
| Scott Myers | 18 |
| Gustavo Mahler | 16 |
| Maged Shenouda | 16 |
| Jeffrey Meckler | 15 |
| Omid Farokhzad | 15 |
| Jeff Paley | 14 |
| Diego Miralles | 14 |
| Carlos Alberto Boero Hughes | 12 |
| Martin Shkreli | 12 |
| Carlos Daniel Silva | 11 |
- Borsa valori
- Insiders
- Horacio Plotkin
- Connessioni Società
